Balversa
Ended Awarded
- Contract number
- 36C26024F0380
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $35,286
Award facts
- Contract value 100% obligated
- $35,285.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a firm fixed price delivery order to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the supply of the chemotherapy drug BALVERSA (erdafitinib). This order is issued against Janssen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a $3.1 billion multiple award schedule that allows VHA to procure prescription drugs. The potential value of this specific delivery order is $35,285.90, with a completion date of June 26, 2024. Janssen, a for-profit manufacturer of pharmaceutical and biologic products, has been awarded numerous prime contracts by the VA to provide vital medications to support healthcare services for veterans across the country. No set-aside designation was used for this contract.
Quick answers
Who was awarded contract 36C26024F0380?
36C26024F0380 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on April 26, 2024.
How much is contract 36C26024F0380 worth?
The government has obligated $35,286 on 36C26024F0380.
Is contract 36C26024F0380 an order under another contract?
Yes. 36C26024F0380 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0380 competed?
The extent of competition for 36C26024F0380 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award